My Account Log in

1 option

CADTH Canadian Drug Expert Committee final recommendation : indication : type 2 diabetes mellitus. Empagliflozin / metformin hydrochloride (Synjardy -- Boehringer Ingelheim Canada Ltd.) / CADTH Canadian Drug Expert Committee.

NCBI Bookshelf Available online

View online
Format:
Book
Author/Creator:
CADTH Canadian Drug Expert Committee, author, issuing body.
Language:
English
Subjects (All):
Type 2 diabetes.
Drug interactions.
Physical Description:
1 online resource (5 pages)
Place of Publication:
Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 2016.
Summary:
The CADTH Canadian Drug Expert Committee (CDEC) recommends that empagliflozin and metformin hydrochloride (empagliflozin/metformin) fixed-dose combination (FDC) be reimbursed for patients with type 2 diabetes mellitus.
Notes:
Description based on publisher supplied metadata and other sources.

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account